Indianapolis, IN – September 2, 2025 — CAI, a global professional services firm renowned for Operational Readiness and Operational Excellence, today announced a strategic partnership with phData, a leader in data engineering and AI/ML solutions. Together, the companies will deliver intelligent, scalable technologies that help pharmaceutical and biotech manufacturers speed facility readiness, minimize operational delays, and maintain unwavering regulatory compliance.

By uniting CAI’s decades-deep expertise in commissioning, qualification, and quality with phData’s advanced capabilities in data architecture, artificial intelligence, and machine learning, the partnership equips life-science organizations to:

• Unlock data-driven insights through AI-powered analytics, digital twins, and intelligent automation.

• Shrink time-to-market by streamlining validation and startup activities.

• Reduce risk and cost by automating labor-intensive compliance tasks.

• Improve patient outcomes via faster, more reliable delivery of safe, effective therapies.

A recent joint initiative illustrates the impact: CAI and phData developed an AI-enhanced methodology that compares up to 100,000 pages of documentation against thousands of Good Practice (GxP) requirements in minutes. The solution—powered by proprietary large-language-model (LLM) natural-language processing and a human-in-the-loop workflow—cuts thousands of labor hours from traditional manual gap analyses while instantly surfacing compliance concerns for expert review.

“Our partnership with phData is accelerating how life sciences organizations achieve operational readiness in an increasingly complex, data-driven world,” said Jackie Karceski, Chief Technology Officer at CAI. “By embedding AI into compliance and quality workflows, we’re enabling our clients to move faster, reduce risk, and maintain the highest regulatory standards—while freeing expert teams to focus on what matters most: patient outcomes and innovation.”

“Partnering with CAI allows us to bring together deep business intelligence and industry-specific insight to solve some of the most complex challenges in Life Sciences. By combining phData’s strengths in AI, machine learning, and data engineering with CAI’s operational excellence and regulatory knowledge, we will enable our clients to accelerate innovation, ensure compliance, and ultimately improve patient outcomes,” said Dominick Rocco, Vice President of AI/ML at phData.

The collaboration embodies CAI’s 2025 brand promise—delivering accelerated readiness and operational excellence—and sets a new benchmark for digital transformation in regulated environments.

About CAI

CAI is a global professional services firm providing technical, operational, and project-management support to life-science, data-center, and other mission-critical industries. CAI’s elite experts and proven methodologies accelerate operational readiness and drive sustainable success. Learn more at www.caiready.com.

About phData

phData is a leading AI and data-engineering consulting firm that helps organizations build and scale machine-learning and analytics solutions with confidence. From robust data-platform engineering to enterprise-grade AI strategy, phData transforms data into actionable intelligence. Visit www.phdata.io for more information.

Media Contact

LifeSciences@caiready.com | +1 317-271-6082

Technical Contact:

Jonathon Thompson, Director of Digital Products, CAI | jonathon.thompson@cagents.com